Pharmaceutical companies
For clinical translation of designed therapeutic platforms, regulatory navigation and market access. Open to licensing of specific design assets or longer-term programme partnerships.
Partners
Selective collaboration on terms that protect the work.
Noviota’s commercial route to market is collaboration. Noviota designs and owns the intellectual property. Partners deliver experimental capacity, manufacturing infrastructure and clinical translation.
Contract research organisations
For experimental validation of designs produced through the Nanomedicine Design Stack. Particular interest in CROs with strength in lipid nanoparticle characterisation and cellular delivery systems.
Academic groups
For collaborative research at the intersection of synthetic biology, nanomedicine and standardised biological description. Co-authorship on shared work where it makes sense for both parties.
Manufacturing partners
For reproducible production of designed therapeutic systems at scales appropriate to clinical development. Process-rigorous partners with documentation cultures that match ours.
Considering a collaboration?
Email partnerships directly, or use the contact form.